News

Nexus Pharmaceuticals, Inc. announced that it has received US Food and Drug Administration (FDA) approval for EMERPHED (ephedrine sulfate injection) in 25mg/5mL and 50mg/10mL…
Read More...

Oragenics, Inc. announced that the Company has entered into an exclusive global license agreement with Inspirevax Inc. for its novel intranasal mucosal adjuvant, BDX301, for the…
Read More...

The European Commission has granted marketing authorization in the European Union (EU) for Nubeqa (darolutamide), an oral androgen receptor inhibitor (ARi), plus androgen deprivation…
Read More...

ImmunoGen, Inc. announced a global, multi-target license and option agreement whereby it granted Vertex Pharmaceuticals (Vertex) (NYSE: VRTX) rights to conduct research using…
Read More...

BioNxt Solutions Inc. is pleased to report that it has executed an agreement to carry out its comparative drug absorption study for the Company’s transdermal (“TDS”) Rotigotine patch…
Read More...

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration (FDA) has approved Kevzara (sarilumab) for the treatment of polymyalgia rheumatica (PMR),…
Read More...

Sunshine Biopharma Inc. announced the signing of an exclusive worldwide license agreement (the “License Agreement”) with the University of Arizona. The License Agreement grants Sunshine…
Read More...

Tevard Biosciences, Inc., the pioneer of tRNA-based therapies for severe genetic diseases, announced a four-year global research collaboration with Vertex Pharmaceuticals Incorporated…
Read More...

Reata Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (“FDA”) has approved SKYCLARYS (omaveloxolone) for the treatment of Friedreich’s ataxia in adults and…
Read More...

Tempus, a leader in artificial intelligence (AI) and precision medicine, today announced a multi-year, strategic collaboration with Pfizer in which the two companies are working…
Read More...

Rhythm Pharmaceuticals, Inc. announced that Rhythm’s Netherlands subsidiary, Rhythm Pharmaceuticals Netherlands B.V. (“Rhythm BV”), acquired Xinvento B.V., a Netherlands-based biotech…
Read More...

Azenta, Inc. announced the launch of the Cryo Store Pico™ ("Pico"), a novel automated cryogenic storage system designed for high-value biological samples used in the many stages of life…
Read More...

AbbVie announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of upadacitinib (RINVOQ, 45 mg and 15 mg and 30 mg…
Read More...

Singleron Biotechnologies, a front-runner in single cell multi-omics analysis, and Macrogen Europe, a state-of-the-art sequencing provider of fast and reliable genome analysis services…
Read More...

Ocugen, Inc. announced that it has submitted an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial of…
Read More...

Lantern Pharma Inc., a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("AI") and machine learning (“ML”) platform to transform the cost,…
Read More...

Keymed Biosciences Inc. and Lepu Biopharma Co., Ltd  jointly announce a global exclusive licence agreement with AstraZeneca for CMG901, a potential first-in-class Claudin 18.2 antibody…
Read More...

Xspray Pharma AB has signed an agreement with EVERSANA to support the U.S. launch and commercialization of the company's first innovative cancer therapy Dasynoc for the treatment of…
Read More...

Sage Therapeutics, Inc. announced the European Medicines Agency (EMA) granted Orphan Drug Designation to SAGE-718 for the treatment of Huntington’s disease (HD). SAGE-718 is in…
Read More...

Moderna, Inc. and Life Edit Therapeutics Inc., an ElevateBio company announced a strategic research and development collaboration to discover and develop in vivo mRNA gene editing…
Read More...